Search

Search Constraints

You searched for: Author/Creator ,

Search Results

42597. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Issue 12 (5th September 2016)

42598. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial. Issue 12 (December 2019)

42599. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial. Issue 12 (December 2019)